Last updated on February 2019

Open-Label Extension and Safety Study of Talazoparib


Brief description of study

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Clinical Study Identifier: NCT02921919

Find a site near you

Start Over